Home Current Issue Previous Issues Published Ahead-of-Print Collections For Authors Journal Info
Skip Navigation LinksHome > April 2013 - Volume 62 - Issue > Welcome 14th Annual International Meeting of the Institute o...
Text sizing:
A
A
A
JAIDS Journal of Acquired Immune Deficiency Syndromes:
doi: 10.1097/01.qai.0000429199.30440.e5
Program Information and Acknowledgements

Welcome 14th Annual International Meeting of the Institute of Human Virology

Free Access

at the University of Maryland School of Medicine

By: Dr. Robert C. Gallo, M.D.

Co-Founder & Director, IHV

Dear Colleagues and Friends,

This year’s meeting will be held in Baltimore Sunday, October 14 – Wednesday, October 17. Leading virologists will descend upon the City to share and examine innovative scientific breakthroughs in HIV/AIDS biology - from basic science to clinical research. We will also hear from distinguished experts on HIV-associated diseases and malignancies. Additionally, we will again include our popular Special Symposium on Africa to review and address the development of clinical research capacity on the continent and issues related to health care delivery in resource-poor countries.

Our meeting returns to the beautiful Marriott Waterfront Hotel located in the Harbor East community of Baltimore City. This premiere venue not only has spectacular views of Baltimore’s renowned Inner Harbor area, but also provides easy access to the city’s finest shopping and restaurants.

In addition to our scientific sessions, we look forward to this year’s IHV Awards Gala on the evening of Tuesday, October 16. IHV will honor Thomas Waldmann, M.D. as our Lifetime Achievement Award recipient for Scientific Contributions. Tom is Head of the Cytokine Immunology and Immunotherapy Section at NIH’s National Cancer Institute, where he has now served for more than five decades. Tom has made many key contributions to the field of immunology – both in basic and clinical research and especially to our knowledge of normal and abnormal T-cell biology. His work has had a major impact on the researchers at IHV, and truly all over the world. This also includes his pioneering and seminal contributions to the Human T-lymphotropic virus Type I (HTLV-1).

The 2012 IHV Lifetime Achievement Award in Public Service will be presented to Yi Zeng, Ph.D., Dean of the College of Life Science and Bioengineering at Beijing University of Technology. Professor Zeng has been an illustrious virologist and cancer researcher for many decades in China, a leader of several Chinese Institutions and an Academician of the Chinese Academy of Sciences. Of all his contributions, he is best known for his discovery of the first example of co-carcinogenesis in humans through the combination of infection with Epstein-Barr virus (EBV) and chemical products from ingestion of particular foods derived from certain plants in Southern China.

IHV is also pleased to present a Lifetime Achievement Award for Excellence in Medical Education, Clinical Care, and Clinical Research to John Bartlett, M.D., Professor of Medicine in the Division of Infectious Diseases at The Johns Hopkins University School of Medicine. He served as Chief of the Infectious Diseases Division at the School for 26 years, stepping down in July of 2006. Dr. Bartlett has established himself as the leading infectious disease expert in the world.

We look forward to you joining us in Baltimore to explore the most recent and important developments in HIV/AIDS research and to honor each of the Award recipients for their work in advancing human health.

Sincerely,

Robert C. Gallo, MD

Director and Professor

Institute of Human Virology

Back to Top | Article Outline

Mission Statement

The Institute of Human Virology (IHV) is a world-class center of excellence focusing on chronic viral diseases and virally linked cancers. IHV is dedicated to biomedical research leading to improved treatment and prevention of these diseases.

Our unique structure connects cohesive, multidisciplinary research and clinical programs so that new treatments are streamlined from discovery to patients. IHV is forging local and international programs for research and treatment of human disease.

Robert C. Gallo

Director

Co-Director, Division of Basic Science and Vaccine Research

William A. Blattner

Associate Director

Director, Division of Epidemiology and Prevention

Robert R. Redfield

Associate Director

Director, Division of Clinical Care and Research

C. David Pauza

Associate Director

George Lewis

Co-Director, Division of Basic Science and Vaccine Research

Joseph L. Bryant

Director, Division of Animal Models

Dave Wilkins

Chief Operating Officer

Back to Top | Article Outline

Board of Advisors

Terry Lierman (Chair)

Partner, Summit Global Ventures

Rockville, MD

Robert Charrow

Greenberg-Traurig, LLP

Washington, DC

Janet Langhart Cohen

Langhart Communications

Chevy Chase, MD

Barbara J. Culliton

Science Journalist and

Policy Consultant

Washington, DC

Elijah Cummings

US House of Representatives

Baltimore, MD

Mr. John Evans

Evans Telecommunications

Ft. Lauderdale, FL

Arthur J. Gajarsa

United States Court of Appeals

for the Federal Circuit (Ret)

Washington, DC

Mr. Robert Gray

Chairman, Gray and Company II

Miami Beach, FL

Stewart Greenebaum

Greenebaum & Rose

Associates, Inc.

Baltimore, MD

Ernest F. Hollings

Medical University of

South Carolina

Charleston, SC

Harry Huge

Charleston, SC

Mark Kaplan

University of Michigan

Medical Center

Ann Arbor, MI

Sheilah A. Kast

WYPR Radio

College Park, MD

Honorable Nancy Kopp

State Treasurer

Maryland State Government

Annapolis, MD

Reinhard Kurth

Ernst Schering Foundation

Berlin, Germany

Mr. Thomas Lynch

Amarin Pharmaceutical, Ltd.

Dublin, Ireland

HRH Princess

Chulabhorn Mahidol

Mahidol University

Bangkok, Thailand

Sharon Malone

Fox Hall Ob-Gyn

Washington, DC

Timothy Moynahan

Moynahan & Minella, LLC

Waterbury, CT

Franco Nuschese

Georgetown Entertainment Group

Washington, DC

Joseph Pagano

University of North Carolina

at Chapel Hill

Chapel Hill, NC

Peter Palese

Mount Sinai School of Medicine

New York, NY

Jeffrey Trammell

Trammel and Company

Washington, DC

Lenny Wilkens

National Basketball Association Hall

of Fame Coach and Player

Medina, WA

Back to Top | Article Outline

Ex-Officio Members

Robert C. Gallo

Director

Institute of Human Virology

William E. Kirwan

Chancellor

University System of Maryland

E. Albert Reece

Dean

University of Maryland

School of Medicine

Back to Top | Article Outline

Scientific Advisory Board

Joseph Pagano, MD (Chair)

Chair

Scientific Advisory Board

University of North Carolina

Chapel Hill School of Medicine

Edward A. Berger, PhD

National Institutes of Health

Farley R. Cleghorn, MD, MPH

Constella Futures

Myron S. Cohen, MD

University of North Carolina

Chapel Hill

Max Essex, DVM, PhD

Harvard AIDS Institute

Warner Greene, MD, PhD

Gladstone Institute of Virology and Immunology

William Hall, MD

University College Dublin

Mark Kaplan, MD, FACP

University of Michigan

Medical Center

Michel Klein, PhD

Canadian Network for Vaccines

and Immunotherapeutics

Erling C. J. Norrby, MD, PhD

The Royal Swedish Academy

of Sciences

William Paul, MD

National Institutes of Health

Mario Stevenson, PhD

University of Miami

Sten Vermund, MD, PhD

University of Alabama

Back to Top | Article Outline

Organizing Committees

The Institute of Human Virology at the University of Maryland School of Medicine is grateful for the assistance provided by our Organizing Committees.

Back to Top | Article Outline

International Organizing Committee

William Hall, MD, PhD

Centre for Research in Infectious Diseases

Dublin, Ireland

Robert Siliciano, MD, PhD

Johns Hopkins University

School of Medicine

Baltimore, MD

Arsene Burny, PhD

University of Brussels

Brussels, Belgium

John Moore, PhD

Weill Medical College of Cornell University

New York, New York

Alain Lafeuillade, MD

Department of Infectious Diseases

Toulon, France

David Montefiore, PhD

Duke University Medical Center

Durham, North Carolina

James Mullins, PhD

University of Washington

Seattle, Washington

Anna Linda Zignego

University of Florence

Firenze, Italy

Paolo Rossi, MD, PhD

Ospedale Bambino Gesu

Rome, Italy

Guido Poli, MD

San Raffaele Scientific Institute

Milano, Italy

Ligia Peralta, MD, FAAP, FSAM

University of Maryland

Medical System

Baltimore, MD

Kevin Cullen, MD

Director, Marlene and Stewart

Greenebaum Cancer Center

University of Maryland

Medical School

Baltimore, MD

Back to Top | Article Outline

Local Organizing Committee

C. David Pauza

Institute of Human Virology

Baltimore, MD

Lai-Xi Wang

Institute of Human Virology

Baltimore, MD

Alfredo Garzino-Demo

Institute of Human Virology

Baltimore, MD

Fabio Romerio

Institute of Human Virology

Baltimore, MD

Eric Sundberg

Institute of Human Virology

Baltimore, MD

Alash’le Abimiku

Institute of Human Virology

Baltimore, MD

Ligia Peralta

University of Maryland

School of Medicine

Baltimore, MD

Back to Top | Article Outline

Communications and Press Policy

To enhance the exchange of information and communication among attendees of the Institute of Human Virology Annual International Meeting, the following must be adhered to by all participants:

– All comments at sessions are off-the-record and are not for attribution.

– No coverage, reporting or publication of scientific data or presentations at the Institute of Human Virology Annual Meeting is permitted without the written consent of the presenter(s) and Nora Grannell (info below). This rule applies to all forms of media, including blogging.

One-on-one interviews with scientists and media may be arranged by contacting Nora Grannell, Director of Public Relations and Marketing, Institute of Human Virology, (410) 706-1954 or .

Back to Top | Article Outline

Special Acknowledgements

The Institute of Human Virology at the University of Maryland would like to thank the following organizations. Without their continued and generous support this meeting would not be possible.

Special Benefactor

Gilead Sciences

Profectus Biosciences

Benefactor

Division of AIDS, NIH

National Institute of Allergy and Infectious Diseases

Office of AIDS Research

Underwriter

U.S. Military HIV Research Program

Contributor

Global HIV Vaccine Enterprise

Partec

Merck

Sysmex

The Greenebaum Cancer Center

Back to Top | Article Outline

2012 IHV Lifetime Achievement Award for Scientific Contributions

Thomas A. Waldmann, M.D.

Thomas A. Waldmann, M.D. received his M.D. from Harvard Medical School. He joined the NCI in 1956, and has been Chief of Metabolism Branch since 1973. Over his 56-year career he defined the IL-2 receptor subunits, IL-2R beta and IL-2R alpha using the first-ever reported anti-cytokine receptor monoclonal antibody (anti-Tac, daclizumab, Zenapax). These studies culminated in the definition of the IL-2 receptor as an exceptionally valuable target for monoclonal antibody mediated therapy of leukemia, lymphoma, and multiple sclerosis. He co-discovered IL-15, elucidated its role in persistence of NK and CD8 memory T-cells and completed a first in-human trial of IL-15 in patients with metastatic malignancy. He introduced blockade of the IL-15/IL-15 receptor and its Jak/STAT signaling pathway for leukemias and autoimmune diseases where gamma-c cytokines including IL-15 play a pathogenic role.

Figure. No caption a...
Image Tools

His honors include: the Ehrlich Medal, Abbott Laboratories Prize, Bristol-Myers Squibb Award for Distinguished Achievement in Cancer Research, Milken Family Medical Foundation Distinguished Basic Scientist Award, Artois-Baillet Latour Health Prize, AAI-Dana Foundation Award in Human Immunology Research and election to the National Academy of Sciences, American Academy of Arts and Sciences, Institute of Medicine of the National Academy of Sciences and Royal Society of the Medical Sciences (UK).

Back to Top | Article Outline

2012 IHV Lifetime Achievement Award for Public Service

Yi Zeng, Ph.D.

Professor Yi Zeng, who graduated from Shanghai First Medical College in 1952, is a member of Chinese Academy of Sciences, foreign member of France National Academy of Medical Sciences and Russian Academy of Medical Sciences. He is now Chief of the Department of Oncogenic Viruses and HIV/AIDS of the Institute for Viral Disease Control and Prevention, China CDC, and Dean of the College of Life Science and Bioengineering in Beijing University of Technology. He was formally director of the Institute of Virology, the president of Chinese Association of Preventive Medicine, WHO Expert Advisory Panel on Cancer, and a member of Executive Board of International Union of Microbiology. Yi Zeng is the first scientist to study viral oncology and HIV in China and began his work in this field in 1961. Since 1973 his main focus has been on the relationship between EB virus and nasopharyngeal carcinoma, HPV and esophageal cancer, HBV and liver cancer, HTLV-1 and adult T cell leukaemia, HHV-8 and kaposi sarcoma. In 1984 he began his work on HIV and AIDS.

Figure. No caption a...
Image Tools

Professor Zeng has published more than 500 papers and 6 books in Chinese and English and has been honored with more than 20 awards from the Ministry of Science and Technology of China and Ministry of Health of China. He has also been honored with awards for HIV/AIDS Control and Prevention from British Barry and Martin’s Trust.

Back to Top | Article Outline

2012 IHV Lifetime Achievement Award for Excellence in Medical Education, Clinical Care and Clinical Research

John G. Bartlett, M.D.

John G. Bartlett, M.D., is a Professor of Medicine in the Division of The Johns Hopkins University School of Medicine, Baltimore, Maryland. He served as Chief of the Infectious Disease Division at the School for 26 years, stepping down in July of 2006. Dr. Bartlett received his undergraduate degree at Dartmouth College, Hanover, New Hampshire, and his medical degree at Upstate Medical Center, Syracuse, New York. He trained in internal medicine at the Peter Bent Brigham Hospital, Boston, Massachusetts, and the University of Alabama, Birmingham, and he completed his fellowship training in infectious diseases at the University of California, Los Angeles (UCLA). Before accepting his current position at The Johns Hopkins University, Dr. Bartlett served as a faculty member at UCLA and Tufts University School of Medicine in Boston, Massachusetts, and was associate chief of staff for research at the Boston VA Hospital.

Figure. No caption a...
Image Tools

Dr. Bartlett has worked in several areas of research, all related to his specialty in infectious diseases. His major research interests have included anaerobic infections, pathogenic mechanisms of Bacteroides fragilis, anaerobic pulmonary infections, and Clostridium difficile-associated colitis. Since moving to Johns Hopkins, his major interests have been HIV/AIDS, managed care of patients with HIV infection, and bioterrorism. Dr. Bartlett is a member of the Institute of Medicine, a master of the American College of Physicians, past president of the Infectious Diseases Society of America (IDSA), and a recipient of the Kass Award from the IDSA. In 2005, Dr. Bartlett was awarded the Alexander Fleming Award by the IDSA and the Finland Award from the National Foundation for Infectious Diseases (NFID). Dr. Bartlett has authored over 500 articles and reviews, more than 280 book chapters, and over 60 editions of 18 books. He participates as an editorial board member for numerous journals.

Back to Top | Article Outline

Previous Recipients of Lifetime Achievement Awards

Lifetime Achievement Award for Scientific Contributions

1999 George Klein, Karolinska Institute, Stockholm, Sweden

2000 Maurice Hilleman, Merck Research Laboratories, Sumneytown, Pennsylvania

2001 Hilary Koprowski, Thomas Jefferson University, Philadelphia, Pennsylvania

2002 Alexander Rich, Massachusetts Institute of Technology, Cambridge, Massachusetts

2003 Jan Svoboda, Institute of Molecular Genetics, Prague, Czech Republic

2004 Paul Zamecnik, Massachusetts General Hospital, Boston, Massachusetts

2005 Manfred Eigen, Max Planck Institute, Göttingen, Germany

2006 Maxine Singer, National Institutes of Health, Bethesda, Maryland

2008 Isaac P. Witz, Tel Aviv University, Tel Aviv, Israel

2010 Dr. Rino Rappuoli, Novartis Vaccines in Sienna, Italy

2011 Max Essex, Harvard AIDS Institute

Lifetime Achievement Award for Public Service

2004 Stewart Greenebaum, Greenebaum and Rose Associates, Inc., Baltimore, Maryland

2006 Martin Delaney, Project Inform, San Francisco, California

2008 John D. Evans, Evans Telecommunication Company and The Honorable Robert K. Gray, Gray and Company II, Miami, FL

2010 Harry Huge, Esq.

2011 Bernadine Healy, MD

One-Time Lifetime Achievement Award for Excellence in Teaching

2010 Michele LaPlaca, Bologna, Italy

© 2013 Lippincott Williams & Wilkins, Inc.

Login